**Core Concept**
Simple hyperplasia of the endometrium is a benign condition characterized by thickening of the endometrium due to an increase in the number of endometrial glands and stromal cells. This condition is often caused by unopposed estrogen stimulation, leading to an overgrowth of endometrial tissue.

**Why the Correct Answer is Right**
Progesterone is used to treat simple hyperplasia of the endometrium because it counteracts the effects of estrogen by inducing endometrial differentiation and decidualization. Progesterone binds to the progesterone receptor in the endometrium, leading to the suppression of estrogen-stimulated cell proliferation and the induction of cell maturation. This results in a decrease in the thickness of the endometrium and a reduction in the risk of progression to more severe forms of hyperplasia or malignancy.

**Why Each Wrong Option is Incorrect**
**Option A:** This option is incorrect because it does not specify the duration of progesterone treatment, which is essential for managing simple hyperplasia of the endometrium. A minimum of 6-12 days of progesterone therapy is typically required to effectively induce endometrial decidualization and prevent further estrogen-stimulated growth.
**Option B:** This option is incorrect because it implies that progesterone treatment is only required for a short duration, whereas simple hyperplasia of the endometrium often requires ongoing management to prevent recurrence.
**Option C:** This option is incorrect because it does not provide a specific duration of progesterone treatment, and it may not be sufficient to effectively manage simple hyperplasia of the endometrium.

**Clinical Pearl / High-Yield Fact**
It's essential to note that simple hyperplasia of the endometrium without atypia can be effectively managed with progesterone therapy, but it's crucial to monitor for recurrence and progression to more severe forms of hyperplasia or malignancy.

**Correct Answer:** C. 10-14 days